Clinical Trials Logo

Diabetic Foot Ulcer Mixed clinical trials

View clinical trials related to Diabetic Foot Ulcer Mixed.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05608187 Recruiting - Diabetic Foot Ulcer Clinical Trials

Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers

Start date: September 26, 2022
Phase: Phase 2
Study type: Interventional

A randomized, double-blind, placebo-controlled, parallel, exploratory phase 2a study to evaluate safety and biologic efficacy on wound healing of ILP100-Topical in subjects with diabetic foot ulcers during 26 weeks with a 5-year long-term follow-up period. A total of 30 subjects will be randomized to low dose of ILP100-Topical (ILP100Lo), high dose of ILP100-Topical (ILP100Hi) or Placebo according to a 1:1:1 randomization schedule. The study will consist of a 3-weeks Screening and Run-in Phase, followed by a 5-week Treatment Phase starting from Baseline and an Assessment Phase from Week 5 to Week 26. Thereafter, the subjects will be followed yearly during 5 years in a Long-Term Safety Follow-up Phase.